SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEcobank 31 R Regulatory News (15BX)

Share Price Information for Ecobank 31 R (15BX)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
15BX Live PriceLast checked at - London Stock Exchange

Intraday Ecobank 31 R Share Chart

3rd Quarter Results

30 Nov 2023 17:47

RNS Number : 2942V
Ecobank Transnational Incorporated
30 November 2023
 

Ecobank Group reports Audited Financial Results for the nine months ended 30 September 2023.

 

Profit before tax increased by 12% year-on-year (55% at constant currency) to $450 million on net revenue growth of 12% year-on-year (34% at constant currency) to $1.5 billion.

 

To access these results and press release please follow this link: https://ecobank.com/group/investor-relations/key-figures/performance

Ecobank will not hold an earnings conference call to discuss the audited financial results for the nine months ended 30 September 2023 in alignment with its peers in the market. Hence, we shall hold earnings conference calls only for our half-year and full-year financial results. The 9M 2023 financial results, submitted to the NGX, BRVM and GSE, can be accessed, including the Earnings Press Release, by visiting www.ecobank.com.

If you should have any questions related to these results, please contact Ecobank Investor Relations at: ir@ecobank.com  

 

http://www.rns-pdf.londonstockexchange.com/rns/2942V_1-2023-11-30.pdf

http://www.rns-pdf.londonstockexchange.com/rns/2942V_2-2023-11-30.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTDZMFMNGFGFZM
Date   Source Headline
18th May 202612:22 pmRNSTender Offer Final Results
15th May 20265:32 pmRNSNotice of early redemption of Tier 2 notes
7th May 20261:56 pmRNSTender Offer - Launch Announcement
30th Sep 20251:31 pmRNSResults of Consent Solicitation (2031 Notes)
30th Sep 20251:28 pmRNSResults of Consent Solicitation (2029 Notes)
8th Sep 20259:32 amRNSLaunch of Consent Solicitations
27th May 202512:46 pmRNSPublication of a Prospectus
10th Oct 20243:19 pmRNSPublication of a Prospectus
30th Sep 20247:00 amRNSPublication of a Prospectus - Replacement
27th Sep 20246:30 pmRNSPublication of a Prospectus
30th Nov 20235:47 pmRNS3rd Quarter Results
28th Apr 20234:47 pmRNS1st Quarter Results
31st Mar 202311:57 amRNSEnd of year 2022 Financial Report
8th Dec 20229:04 amRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.